The boss of the Danish pharmaceutical giant behind the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy promised Tuesday to examine lowering their prices in the United States, after comin ...
The net prices of Ozempic and Wegovy, or the amount that Novo Nordisk is actually paid for the drugs, have dropped substantially since their launch and are expected to fall even further, said Lars ...